Companies / Health Care / Life Sciences Tools & Services
Charles River Laboratories stock buybacks
CRL$324Mbought back in the 12 months to Jun 27, 2026
Charles River Laboratories bought back $324M of its stock in the last twelve months, $241M more than it paid out in stock compensation. Its share count is down 2.6% from a year earlier.
Show as table
| Period | Value |
|---|---|
| Q3 '20 | $112,000 |
| Q4 '20 | $74,000 |
| Q1 '21 | $36.0M |
| Q2 '21 | $4.3M |
| Q3 '21 | $143,000 |
| Q4 '21 | $267,000 |
| Q1 '22 | $34.0M |
| Q2 '22 | $4.5M |
| Q3 '22 | $24,000 |
| Q4 '22 | $159,000 |
| Q1 '23 | $19.0M |
| Q2 '23 | $5.0M |
| Q3 '23 | $38,000 |
| Q4 '23 | $139,000 |
| Q1 '24 | $9.4M |
| Q2 '24 | $8.9M |
| Q3 '24 | $100.8M |
| Q4 '24 | $124,000 |
| Q1 '25 | $353.1M |
| Q2 '25 | $7.4M |
| Q3 '25 | $93,000 |
| Q4 '25 | $96,000 |
| Q1 '26 | $208.3M |
| Q2 '26 | $115.6M |
Show as table
| Period | Value |
|---|---|
| Q3 '20 | 50.7M |
| Q4 '20 | 51.5M |
| Q1 '21 | 51.1M |
| Q2 '21 | 51.3M |
| Q3 '21 | 51.6M |
| Q4 '21 | 51.7M |
| Q1 '22 | 51.3M |
| Q2 '22 | 51.3M |
| Q3 '22 | 51.3M |
| Q4 '22 | 51.3M |
| Q1 '23 | 51.4M |
| Q2 '23 | 51.5M |
| Q3 '23 | 51.6M |
| Q4 '23 | 51.3M |
| Q1 '24 | 51.8M |
| Q2 '24 | 51.8M |
| Q3 '24 | 51.6M |
| Q4 '24 | 51.2M |
| Q1 '25 | 50.9M |
| Q2 '25 | 49.3M |
| Q3 '25 | 49.4M |
| Q4 '25 | 48.7M |
| Q1 '26 | 49.0M |
| Q2 '26 | 48.0M |
$116Mlast quarter (Q2 2026)
$241Mnet of stock compensation ($83M)
−2.6%diluted shares, 1 year
−2.1%diluted shares, 5 years
—dividends, 12 months
87%of free cash flow ($371M) spent on buybacks
$0raised by issuing stock, 12 months
47.7Mshares outstanding (Jul 25, 2026)
By fiscal year
Questions
- Does Charles River Laboratories buy back its stock?
- Charles River Laboratories bought back $324M of its stock in the last twelve months, $241M more than it paid out in stock compensation. Its share count is down 2.6% from a year earlier.
- How much did Charles River Laboratories spend on buybacks in fiscal 2025?
- $361M, according to its 10-K for the fiscal year ending Dec 27, 2025.
- Is Charles River Laboratories's share count going down?
- Its diluted share count changed −2.1% over five fiscal years and −2.6% over the last year.
Latest filing used: 10-Q for the period ending Jun 27, 2026, filed Aug 5, 2026 · open on SEC.gov